News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Biogen
NEWS
JOBS
IN THE PRESS
NEWS
Business
Biogen Taps Former Spark Therapeutics Exec and a Finance Vet for Hemophilia Spin-off Company Bioverativ
November 15, 2016
·
3 min read
Drug Development
3 Reasons That Make Biogen the King of a Crumbling Empire
November 11, 2016
·
2 min read
Drug Development
The Small-Cap Biotech That Could Take Down Biogen, Celgene, Eli Lilly and Gilead in Alzheimer’s
November 9, 2016
·
2 min read
Drug Development
Stocks Rocket as Biogen, Ionis Pharma Halt Study on Positive Phase III
November 7, 2016
·
2 min read
Deals
Why Merck & Co. and Allergan Won’t Buy Biogen
November 4, 2016
·
4 min read
Genetown
Why Biogen, bluebird bio and Xencor are 3 Stocks to Look at in November
November 3, 2016
·
2 min read
Deals
Here’s Why Biogen Should Buy Ionis Pharma
November 1, 2016
·
2 min read
Genetown
The Good (Celgene) And Bad (Biogen) Ways To Deliver Drug Revenue Growth
October 28, 2016
·
1 min read
Genetown
Novartis AG Is Challenging Biogen On Biogen’s Own Turf
October 27, 2016
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Genetown
FDA Extends Review of Biogen Idec, Inc. (Massachusetts) MS Drug
October 18, 2012
·
1 min read
Drug Development
Biogen Idec, Inc. (Massachusetts) Says New Look at Data Bolsters Oral MS Drug
October 15, 2012
·
1 min read
Drug Development
Biogen Idec, Inc. (Massachusetts) Release: New Data From Phase 3 Studies Provide Additional Evidence Supporting Treatment Effect for Oral BG-12 (Dimethyl Fumarate) in Multiple Sclerosis
October 12, 2012
·
1 min read
Drug Development
Biogen Idec, Inc. (Massachusetts) Release: TYSABRI® (natalizumab) Data at ECTRIMS Reaffirm Positive Effects of Treatment for People With Relapsing Forms of MS
October 11, 2012
·
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts)'s Commitment to MS Demonstrated Through Significant Scientific Data Being Presented at the 28th ECTRIMS
October 10, 2012
·
1 min read
Business
Biogen Idec, Inc. (Massachusetts) to Report Third Quarter 2012 Financial Results on October 25, 2012
October 5, 2012
·
1 min read
Drug Development
Biogen Idec, Inc. (Massachusetts) Says Hemophilia B Medicine Reduced Bleeding
September 26, 2012
·
9 min read
Drug Development
Biogen Idec, Inc. (Massachusetts)'s MS Drug With Unusual History Shows Promise
September 20, 2012
·
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts) Employees Participate in 80 Volunteer Projects in 22 Countries as Part of Annual “Care Deeply Volunteer Day”
September 14, 2012
·
1 min read
Genetown
Biogen Idec Foundation Awards $1 Million to Museum of Science, Boston to Support Stem Education in Massachusetts
September 12, 2012
·
1 min read
